drug protocol number

CKJX839A1S

drug sponsor

Novartis

drug study

LEQVIO

drug trial site

Dallah Hospital (Riyadh),International Medical Center (Jeddah), Armed Force Hospital (Tabuk) , My Clinic (Jeddah) Mouwasat Hospital (Dammam)

drug status

Ongoing

drug phase